KCL Infra projects board approves unaudited standalone financial results for Q2FY27 and H1FY27
BSE India
KCL Infra projects board of directors approves the unaudited standalone financial results for the quarter and half-year ended 30th September 2026. The results include a Limited Review Report issued by the Statutory Auditor. The announcement follows a previous board meeting held on 3rd November 2026. No specific financial figures or segmental performance drivers are provided in this administrative outcome notice.
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 65.09 19.43 1.02 234.95% 6253.86%
EBITDA 1.98 1.05 -0.30 89.26% 751.92%
Op. profit margin(%) 1.48 1.15 -63.86 28.73% 102.32%
Net Profit 1.30 0.67 -0.33 93.89% 492.03%
EPS 0.08 0.04 -0.02 100.00% 500.00%
* Standalone data
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 7.09 4.55 6.23 55.84% 13.80%
EBITDA 1.33 -0.66 -0.52 301.09% 355.50%
Op. profit margin(%) 15.68 -19.46 -12.86 180.56% 221.94%
Net Profit 0.78 -1.20 -0.92 165.21% 185.00%
EPS 1.83 -2.81 -2.16 165.12% 184.72%
* Standalone data
162.28
-1.89%
Dhampur Sugar Mills reports Q2FY27 results and appoints new Cost Auditor for casual vacancy
BSE India
Dhampur Sugar Mills announces its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The board appoints Bahadur Murao Co. Cost Accountants as the new Cost Auditor to fill the vacancy left by the demise of Mr. SR Kapur. Additionally, the company extends the long-stop date for its 51% equity stake acquisition in Venus India Asset-Finance Private Limited to March 31, 2027.
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 503.16 552.62 504.19 -8.95% -0.20%
EBITDA 46.77 37.12 11.36 26.00% 311.71%
Op. profit margin(%) 8.16 5.66 1.89 44.20% 332.75%
Net Profit 12.57 6.03 -7.88 108.46% 259.52%
EPS 1.96 0.94 -1.23 108.51% 259.35%
* Consolidated data
Navigant Corporate approves H1FY27 unaudited financial results and appoints Varun Kacholia as Additional Director
BSE India
Navigant Corporate's board approves the unaudited financial results for the half-year ended September 30, 2026. The board also appoints Mr. Varun Kacholia as an Additional Director in the Executive Category effective November 14, 2026. The trading window remains closed until November 16, 2025, to facilitate the declaration of these results. The company confirms Mr. Kacholia is not related to any existing directors and holds no regulatory debarments.
28.88
4.98%
Magnus Steel and Infra board approves unaudited standalone financial results for Q2FY27
BSE India
Magnus Steel and Infra board of directors approves the unaudited standalone financial results for the quarter ended September 30, 2026. The results include the Independent Auditors Review Report as recommended by the Audit Committee. The announcement serves as a formal disclosure of quarterly performance metrics. The company confirms that extracts of these results will be published in newspapers to ensure regulatory compliance.
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 4.71 7.30 7.28 -35.53% -35.37%
EBITDA 0.86 2.41 1.58 -64.52% -45.76%
Op. profit margin(%) 18.17 33.02 21.65 -44.96% -16.07%
Net Profit 0.86 2.41 1.50 -64.52% -42.97%
EPS 2.53 7.13 4.44 -64.52% -43.02%
* Standalone data
logo
Apis India Ltd.
14 Nov 2026
50.47
-1.19%
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 113.90 65.96 96.25 72.67% 18.34%
EBITDA 14.66 7.13 11.44 105.60% 28.15%
Op. profit margin(%) 10.62 9.43 11.49 12.63% -7.62%
Net Profit 4.47 3.39 7.08 32.03% -36.82%
EPS 0.32 0.25 12.96 28.00% -97.53%
* Consolidated data
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 0.00 0.00 0.00 - -
EBITDA -1.10 -0.08 -0.07 -1326.62% -1520.21%
Op. profit margin(%) -550050.00 - - - -
Net Profit -9.17 -8.16 -8.13 -12.47% -12.86%
EPS -0.87 -0.78 -0.77 -11.54% -12.99%
* Standalone data
366.30
0.98%
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 769.92 656.96 535.10 17.20% 43.88%
EBITDA 19.28 22.22 18.49 -13.22% 4.29%
Op. profit margin(%) 2.19 3.07 3.01 -28.60% -27.09%
Net Profit 1.43 3.79 1.51 -62.28% -5.31%
EPS 2.33 6.17 2.46 -62.24% -5.21%
* Consolidated data
Norris Medicines board approves unaudited financial results and limited review report for Q2FY27
BSE India
Norris Medicines board of directors approves the unaudited financial results and limited review report for the quarter and half-year ended September 30, 2026. The company plans to publish these financial results in newspapers as per regulatory requirements. This announcement follows a formal board meeting held on November 14, 2026, to review the periodic performance. No specific financial figures or segmental drivers are provided in this procedural filing.
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 0.66 0.92 2.00 -29.02% -67.18%
EBITDA -0.23 -0.28 -0.49 19.76% 53.60%
Op. profit margin(%) -34.46 -30.48 -24.41 -13.05% -41.15%
Net Profit -0.36 -0.40 -0.72 8.72% 49.57%
EPS -0.36 -0.40 -0.72 10.00% 50.21%
* Standalone data